Small molecules remain a common treatment option, with a chemical compound as its active ingredient.1,2 Small molecules are usually administered orally but may also be injected or infused.2
Small-molecule drugs may provide the best or only current way to treat certain diseases. Because of their size, these compounds can pass through cell membranes to engage targets inside the cell.1 They can also be designed to cross the blood-brain barrier and engage targets that may contribute to neurological illnesses.3
Learn more about small molecule targets:
KIF18A , KRASG12C, MCL-1, PRMT5, proteasome.
Search our clinical trials.
Visit our resources section for further information on modalities currently under investigation.
1. National Cancer Institute. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/small-molecule-drug. Accessed 7/30/2020. 2. ASCO Cancer.net. https://www.cancer.net/navigating-cancer-care/how-cancer-treated/personalized-and-targeted-therapies/understanding-targeted-therapy. Accessed 8/6/2020. 3. Pardridge WM. J Cereb Blood Flow Metab. 2012;32(11):1959-1972.